A
Anat Loewenstein
Researcher at Tel Aviv Sourasky Medical Center
Publications - 443
Citations - 12603
Anat Loewenstein is an academic researcher from Tel Aviv Sourasky Medical Center. The author has contributed to research in topics: Macular degeneration & Visual acuity. The author has an hindex of 50, co-authored 406 publications receiving 9997 citations. Previous affiliations of Anat Loewenstein include Johns Hopkins University & Westmead Hospital.
Papers
More filters
Journal ArticleDOI
Fluid-based prognostication in n-AMD: Type 3 macular neovascularisation needs an analysis in isolation.
Ashish Sharma,Nikulaa Parachuri,Nilesh Kumar,Francesco Bandello,Baruch D. Kuppermann,Anat Loewenstein,Carl D. Regillo,Usha Chakravarthy +7 more
TL;DR: The purpose of this editorial is to highlight the need for the analysis of the type 3 lesion as a separate entity in relation to the fluid (IRF and SRF) based recommendations.
Journal Article
Performance of a novel deep learning algorithm for Automatic Retinal Fluid Quantification in Home OCT Images
David R Lally,Judy E. Kim,Michael J. Elman,Oren Tomkins-Netzer,Yael Alon,Elad Bergman,Anat Loewenstein +6 more
Journal Article
[intravitreal injection - a small procedure for the eye, a giant leap for ophthalmology].
Elad Moisseiev,Anat Loewenstein +1 more
TL;DR: This review will cover the development of intravitreal injection treatment, describe the injected drugs, the injection technique and its possible complications, and the commonly used treatment protocols.
Journal ArticleDOI
PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: Long-Term Visual Acuity May Improve With Higher Injection Index.
Wei Gui,Adrian Au,Gilad Rabina,Noa Kapelushnik,Shai Cohen,Dua Masarwa,Hamid Hosseini,Gad Heilweil,Shulamit Schwartz,Anat Loewenstein,Steven D. Schwartz +10 more
TL;DR: Increased II was associated with better mean VA, suggesting that long-term continuous vascular endothelial growth factor suppression may improve VA in eyes thought to carry poor prognoses.
Journal ArticleDOI
The management of neovascular age‐related macular degeneration: A systematic literature review of patient‐reported outcomes, patient mental health and caregiver burden
Richard O. Gale,Robert Finger,Bora Eldem,Tariq Aslam,Janice Barratt,Vincent Daien,Laurent Kodjikian,Anat Loewenstein,Mali Okada,Tien Yin Wong,M. Sylvanowicz,Francisco Rodríguez +11 more
TL;DR: A coordinated holistic approach to patient care is key to optimizing patient well-being as well as visual outcomes, and standardization of QoL studies would assist in establishing whether sustainedQoL improvement, rather than prevention of QOL decline, should be a realistic expectation of treatment of nAMD in the longer term.